Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Amello Jason Create: Alert

All | News | Filings
Date FiledTypeDescription
05/02/2023 4 Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $1.29, valued at $116.1k
03/16/2023 4 Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $1.67, valued at $33.4k
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2022 4 Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 230,000 options to buy @ $3.21, valued at $738.3k
01/19/2022 4 Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 18,500 options to buy @ $2.21, valued at $40.9k
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2018 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Paid exercise price by delivering 22,235 shares @ $8.94, valued at $198.8k
03/02/2018 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 19,500 shares @ $0
Granted 27,700 options to buy @ $14.3, valued at $396.1k
10/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2017 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
02/24/2016 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 26,000 shares @ $0
Granted 39,650 options to buy @ $7.7, valued at $305.3k
03/10/2015 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 45,000 options to buy @ $11.15, valued at $501.8k
12/01/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/05/2014 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 21,667 options to buy @ $22.8, valued at $494k
03/27/2014 4 Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Bought 4,000 shares @ $17, valued at $68k
05/14/2013 4 Amello Jason (Executive Vice President & CFO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC
Txns: Paid exercise price by delivering 2,623 shares @ $1.65, valued at $4.3k
01/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/10/2012 4 Amello Jason (Executive Vice President & CFO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC
Txns: Granted 25,000 shares @ $0
04/06/2011 4 Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 4 on GENZYME CORP
Txns: Unknown transaction of 2,084 shares @ $74, valued at $154.2k
Disposed/sold 5,005 shares @ $74, valued at $370.4k
Exercised 1,818 restricted stock units @ $0
Exercised 1,740 restricted stock units @ $0
Exercised 1,447 restricted stock units @ $0
Disposed/sold 4,340 options to buy @ $51.52, valued at $223.6k
Disposed/sold 5,455 options to buy @ $58.66, valued at $320k
Disposed/sold 5,220 options to buy @ $68.48, valued at $357.5k
Disposed/sold 4,725 options to buy @ $62.16, valued at $293.7k
Disposed/sold 8,640 options to buy @ $58.5, valued at $505.4k
Disposed/sold 9,300 options to buy @ $62.98, valued at $585.7k
09/02/2010 4 Amello Jason (Corp Contrllr,ChiefAccntOfficr) has filed a Form 4 on GENZYME CORP
Txns: Sold 6,640 shares @ $70.3, valued at $466.8k
Exercised 6,640 options to buy @ $46.24, valued at $307k
06/18/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2010 4 Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 4 on GENZYME CORP
Txns: Sold 533 shares @ $45.62, valued at $24.3k
Exercised 1,575 restricted stock units @ $0
05/26/2009 4 Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 4 on GENZYME CORP

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy